SA Asks: How will changes at FDA impact vaccine makers?
Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...
Hosted on MSN1mon
Johnson & Johnson (JNJ): One of the Best Vaccine Stocks to Buy According to Hedge Funds
Johnson & Johnson (NYSE:JNJ) reported sales of $88.8 billion for fiscal year 2024, reflecting a 4.3% year-over-year growth. Its revenue reached $22.5 billion in revenue, marking a 5.2% year-over ...
Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade)
Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...
AOL1mon
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The E.mbrace study is a ...
Johnson & Johnson Loses in Court Again in Bid to Settle Talc Cases
A judge dismissed an attempt to use a bankruptcy court to resolve tens of thousands of claims that the company’s talcum power ...
J&J shares tumble as judge rejects $10 billion talc settlement
Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal to end ...
Insider Monkey1mon
10 Best Vaccine Stocks to Buy According to Hedge Funds
The company ranks third on our list of the 10 best vaccine stocks to buy according to hedge funds. Johnson & Johnson (NYSE:JNJ) develops, manufactures, and sells a range of products in the ...
Yahoo Finance6d
Johnson & Johnson (NYSE:JNJ) Presents Promising Nipocalimab Data At AAN Annual Meeting
NYSE:JNJ Earnings Per Share Growth as at Mar 2025 ... Additionally, consistent product launches, such as the COVID-19 vaccine, significantly contributed to their health sector's expansion and ...